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ABSTRACT
Objective: At least one million people are suffering from dermatophytosis in India. These mycoses although normally not lethal are unpleasant, 
frequent disease recurrence, and resistant dermatophytic strains cause considerable economic losses. During the antifungal evaluation of essential 
oil of Eugenia caryophyllus, all concentrations were found to be an excellent inhibitor against selected fungi as compared to standard antifungal drugs 
griseofulvin, ketoconazole, and itraconazole. The present work deals with the preparation of an ointment from E. caryophyllus oil for the treatment of 
ringworm infection in human beings.
Materials and Methods: Due to these potent fungicidal properties, an ointment of E. caryophyllus was prepared and topically applied on tinea 
patients attending the outpatient Department of Skin, Venereology, and Leprology, SMS Hospital, Jaipur. Patients were diagnosed as tinea corporis, 
tinea capitis, tinea manuum, and tinea barbae. The medication was done twice a day for 3 weeks as advised by the skin specialist.
Results: All patients showed positive potassium hydroxide (KOH) results at the beginning of the trial. After the 2nd week of treatment, every patient 
was KOH negative and remained negative when re-examined after one month of treatment. All patients were completely cured within 3 weeks of the 
treatment.
Conclusions: Ointment showed excellent results, found cheaper substitutes to cure the disease without any adverse side effect. The present study 
offers a high possibility of complete cure of tinea infection and suggesting its uses as raw material by pharmaceutical industries for the development 
of antidermatophytic drug in prevailing conditions where dermatophytes are becoming resistant against popular antifungals.
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INTRODUCTION
Dermatophytosis poses a serious concern to the sociologically backward 
and economically poor population of India. In dermatophytic infection 
of the skin, the fungus remains confined to the stratum corneum while 
pathogenic changes are produced in the deeper layer of the epidermis 
and dermis as per medical observation. These fungi produced a ring-
shaped lesion of infected skin. Clinical surveys [1-4] carried out in India 
have shown ringworm as one of the most common dermatomycoses 
caused by the species of Epidermophyton, Microsporum, and 
Trichophyton. The disease is predominant in tropical and subtropical 
countries due to their, prevailing moisture and temperature regimes and 
pose a therapeutic problem [5,6]. Despite the availability of new systemic 
antifungal therapies, dermatophytic infections are difficult to eradicate 
completely, with recurrence reported in up to 25%–40% of cases [7]. 
Many antifungal synthetic drugs, namely terbinafine imidazoles and 
butenafine are found effective against dermatophytosis [8]. However, 
disease recurrence, resistant dermatophytic strains, and adverse effects 
are some drawbacks associated with popular antifungals.
In recent years, there has been a gradual revival of interest in the use 
of medicinal plants in developed as well as in developing countries, 
because herbal medicines have been reported to be safe and without 
any adverse side effect thus, a search for new drugs with better and 
cheaper substitutes from plant resources are a natural choice [9-14].
These finding promoted us to explore other plant products which could 
be exploited as effective antifungals. In our previous work, we explored 
Trachyspermum ammi oil against ringworm infection of human beings 
and all patients were cured successively without any adverse effect [15].
Recently, we have carried out the detailed antifungal study of the 
essential oil obtained from the flowering bud of E. caryophyllus in vitro 
as well as in clinical trials against ringworm infection in human beings. 
Eugenia or clove oil has been used as dental care product from the 
ancient time, but no work has been reported as dermal care product till 
now especially for ringworm treatment.
MATERIALS AND METHODS
Oil extraction
Clove flowering buds purchased from the local market of Jaipur 
city in April 2012 were identified by Prof. P. C. Jain, Department of 
Botany, University of Rajasthan, Jaipur. The semi-crushed buds were 
hydrodistilled in a Clevenger’s apparatus for 4 h. Moisture free oil was 
then stored in amber colored bottles and kept in the refrigerator. The 
oil yield was 4.1% (v/w).
Microorganism for in vitro studies
Clove oil was evaluated for their antifungal properties against selected 
pathogens. Trichophyton rubrum and Trichophyton simii were isolated 
from infected skin scrapings of tinea patients from SMS Hospital, Jaipur, 
while Chrysosporium tropicum and Chrysanthemum indicum were 
isolated from soil samples through To. Ka. Va. hair baiting technique 
of Vanbreuseghem [16]. These fungi were maintained on Sabouraud’s 
dextrose agar medium.
Screening of oil
The filter paper disc diffusion assay by Wannisorn et al. [17] was 
used with slightly modification for screening the essential oils against 
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dermatophytes. Standard size Whatman no. 1 filter paper discs 6.0 mm 
in diameter, sterilized by dry heat at 140°C in an oven for 1 h was used to 
determine antifungal activity. 20 ml sterilized Sabouraud’s dextrose agar 
medium was taken in each autoclaved Petri dish and allowed to solidify. 
The fungal spore suspension was prepared in sterilized 0.85% saline water 
by transferring a loopful of 15 day-old culture. 1 ml of spore suspension of 
approximately 0.5–5 × 104 (cfu/ml) was spread over the respective agar 
medium plates. Sterilized filter paper was soaked in neat undiluted oil. 
An oil saturated disc was placed on an agar plate containing fungal spore 
suspension. Ketoconazole was used as a standard drug. These plates were 
incubated. Five replicates were kept in each case, and the average values 
were determined, and inhibition zone (IZ) was observed. The antifungal 
activity was determined by measuring the IZ around the disc. The activity 
of the oil was measured by the following formula.
Activity Index AI
Inhibition Zone IZ  of samples
Inhibit
   
ion Zone IZ  of standard 
Minimum inhibitory concentration (MIC) through semisolid agar 
antifungal susceptibility method:
Semisolid agar antifungal susceptibility testing method of Provine and 
Hadley [18] for endpoint determination (MIC) was carried out in BHIA 
(HiMedia). BHIA was prepared according to manufacturer’s instruction.
Inoculum preparation
Sterile swab dipped into sterile tween 80 was used to pick the pure 
colony of yeast. This was then suspended in 3–4 ml of sterile normal 
saline and vortexed. The turbidity of the homogenous suspension was 
adjusted to ~0.5 McFarland standard. Similarly, inoculum was prepared 
for filamentous fungi (3–7 days old slant at 37°C on potato dextrose 
agar). By swabbing the pure colony (mixture of conidia and hyphal 
fragments) was suspended in 3–7 ml of sterile saline. The mixture was 
vortexed and heavy particles were allowed to settle. The homogenous 
suspension was adjusted to 0.5 McFarland standard.
Inoculation of drug-containing tubes
The semisolid agar tubes containing known concentrations of test oils 
as well as oil-free controls, prepared in duplicate, were inoculated with 
one loopful (HiMedia Flexiloop 4) of 0.5 McFarland adjusted culture 
by inserting the loop deep within the semisolid agar. The tubes were 
incubated at 37°C for 48 h (96 h for dermatophytes). A loopful of the 
inoculum suspension was streaked onto Sabouraud dextrose agar to 
check for purity and viability.
Endpoint determination
Endpoint determination was done according to the NCCLS/CLSI 
guidelines, M27-A, and M38-A. Growth was compared to that of oil-
free control and scored by visual inspection as follows: +4: growth 
same as control; +3: slight decrease in growth; +2: significant reduction 
in growth reduction 80% in yeast and 50% in filamentous; +1 slight 
growth or few visible hyphal fragments; and 0: no growth.
Statistical analysis
Statistical analysis was carried by one-way ANOVA following multiple 
comparison tests Turkeys method. Data are expressed as the mean and 
standard error of the mean.
Ointment preparation and application
About 1% concentration of E. caryophyllus was (clove oil) prepared in 
petroleum jelly and labeled it as ointment EC.
A comparative efficacy of E. caryophyllus with different antimycotic 
drugs such as griseofulvin, itraconazole, and ketoconazole showed that 
all concentrations of E. caryophyllus were found to more effective than 
standard drugs. In our previous work Jain and Sharma, 2003, we also 
used 1% and 2% concentration of T. ammi oil against dermatophytes 
causing ringworm infection of human being and cured all patient 
successively. Before applying this ointment of tinea patients patch test 
of Roxburgh and Borrie [19] was followed to find out whether these 
ointments have any irritant activity or not.
Clinical application
For in vivo investigation, patients (male and female) of different age 
groups (infant to 50 years) were selected. All patients were voluntary. A 
total of 35 patients were selected for study to see the clinical response 
of ointment. This was applied topically on patients to control the fungal 
infection. The medication was done twice a day for 3 weeks as advised 
by the skin specialist. The patients were not allowed to take any other 
systemic or topical therapy during the course of the present study.
Patients were diagnosed for different clinical types such as tinea 
corporis, tinea capitis, tinea manuum, and tinea barbae based on 
site and type of infection. The diagnosis was further confirmed by 
microscopic examination of scrapings (from infected area) treated 
with 10% KOH. Only KOH positive cases were enrolled for the study. 
Patients were examined just before the start of therapy and at the end 
of each week of the treatment, up to their complete cure. At each visit 
of the patient, the same reference lesion was scraped for fungal culture 
to identify the organism and for demonstration of the presence of 
hyphae by microscopic examination of the scraping which was covered 
with 10% KOH preparation. Signs and symptoms of inflammation as 
erythema, scaling, itching, maceration, vesiculation, and pustulation 
were recorded as mild, moderate, severe, or absent. The fungal culture 
was identified by standard protocol.
Additional information of patients regarding their profession, living 
conditions, along with clinical diagnosis-site of infection, primary 
or secondary infection, sex, age were also recorded. Usually, patients 
with secondary infection were avoided for the study. Although the 
cutaneous fungal disease manifested itself in several body areas and all 
the affected areas were treated, only one was selected and designated 




Trichophyton rubrum Trichophyton simii Chrysosporium indicum Chrysosporium tropicum
IZ AI IZ AI IZ AI IZ AI
TC/G TC/I TC/K TC/G TC/I TC/K TC/K TC/G TC/I TC/K
25 25 0.893 1.190 0.490 18 0.750 0.9 0.486 30 1.765 28 0.8 1.647 0.718
50 47 1.679 2.238 0.921 36.33 1.514 1.816 0.982 42 2.470 36 1.028 2.118 0.923
75 75 2.679 3.571 1.470 55 2.292 2.75 1.486 50 2.941 52 1.495 3.078 1.342
100 95 3.393 4.524 1.863 71 2.958 3.55 1.919 57 3.353 58 1.648 3.392 1.479
IZ: Inhibition zone including 6 mm diameter of filter paper disc, AI: Activity index, TC: Test compound. Inhibition zones of standard griseofulvin (G) against Trichophyton 
rubrum=28 mm; Trichophyton simii=24 mm; Chrysosporium tropicum=35 mm. Inhibition zones of standard itraconazole (I) against Trichophyton rubrum=21 mm; 
Trichophyton simii=20 mm; Chrysosporium tropicum=17 mm. Inhibition zones of standard ketoconazole (K) against Trichophyton rubrum=51 mm; Trichophyton 
simii=37 mm; Chrysosporium tropicum=39 mm; Chrysosporium indicum=17 mm
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as the reference lesion. At each visit of the patients, overall clinical 
improvement was reported as none, partial, significant, or completely 
clear by comparing the state of their infection with the state at the time 
of their initial visit. Adverse systemic or local reactions were noted (at 
each visit) and recorded as mild, moderate, or severe.
RESULTS
E. caryophyllus is very well studied nowadays. Lots of works have been 
done on the chemical composition of eugenia oil [20-24]. Eugenol is a 
major constituent of eugenia oil ranging from 82% to 90% according 
to collection time and cultivation place. Other components are trans-β-
caryophyllene, eugenyl acetate, α-humulene, chavicol, β-caryophyllene 
oxide, α-cubebene, α-copaene, and δ-cadinene.
In vitro antidermatophytic activity
Four concentrations of Eugenia oil were prepared and applied against 
selected dermatophytes. Data were compared with the most commonly 
used standard allopathic drugs such as ketoconazole, itraconazole, and 
griseofulvin (Table 1). In the case of C. indicum, all four concentrations of 
clove oil exhibited more prominent inhibitory effects than ketoconazole. 
Griseofulvin and itraconazole were devoid of any antifungal effect against 
this fungus. In the case of T. rubrum, 100%, 75%, and 50% clove oil 
produced 95 mm, 75 mm, and 47 mm IZ, respectively, and had prominent 
efficacy in comparison to griseofulvin (IZ = 28 mm) and itraconazole 
(IZ = 21 mm). A comparative efficacy of this oil with ketoconazole against 
T. rubrum showed that 100% and 75% oil had excellent inhibitory 
properties (Activity index [AI] = 1.863 and 1.470, respectively) while 
50% concentration showed slightly less effect (AI = 0.921). The same 
results were also seen in T. simii and C. tropicum. 100%, 75%, and 50% oil 
showed a more prominent effect than griseofulvin and itraconazole. 25% 
concentration also showed stronger effect than itraconazole in the case 
of C. tropicum (AI = 1.647) and was slightly comparable with itraconazole 
in the case of T. simii (AI = 0.9). Maximum zone of inhibition 95 mm was 
recorded against T. rubrum in the presence of pure oil (Fig. 1).
MIC of clove oil
In present investigation, MIC of clove oil against seven selected fungi, 
namely Candida albicans, T. rubrum, T. verrucosum, M. gypseum, 
M. canis, M. fulvum, and F. verticilloides was carried by SAAS method 
(Table 2). Clove oil showed excellent antidermatophytic activity against 
all test fungi. MIC of clove oil against T. rubrum was found to be 0.05 ± 
0.000 μl/ml followed by 0.1 μ/ml for C. albicans, M. gypseum, M. canis, 
T. verrucosum, and M. fulvum. MIC for F. verticillioides was found to be 
0.2 ± 0.002 μl/ml.
In vivo experiment
Data incorporated in Table 3 show that all the 35 patients of tinea 
infection recovered completely with the timely application of these 
ointments (Figs. 2 and 3).
Tinea corporis
A complete treatment period of tinea corporis differs (4–6 weeks) with 
the different allopathic drug. Out of 15 patients treated with ointment 
EC, three showed complete relief within 1 week, nine patients were 
completely cured in the 2nd week, and the remaining showed complete 
cure during the 3rd week of treatment. Trichophyton rubrum and T. simii 
were the main causative agents of tinea corporis.
Table 2: Minimal inhibitory concentration (µl/ml) of essential 









Fig. 1: Efficacy of Eugenia caryophyllus
Fig. 2: Showing different clinical types of tinea infection
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Tinea capitis
A total of six patients of tinea capitis were treated with ointment EC. All 
patients showed significant improvement in the 2nd week of treatment 
and cured completely within 3 weeks without any adverse side effect.
Tinea manuum
A complete treatment period of tinea manuum is 6–8 weeks with 
different drugs. In present investigation out of nine patients of tinea 
manuum, three patients showed significant improvement in 1st week, 
and rest six in 2nd week. All patients completely cured within 3 weeks.
Tinea barbae
Five patients of tinea barbae suffering from Trichophyton rubrum 
showed significant improvement in 1st week of treatment and 
completely cured in the 2nd week of treatment.
During the present study, all patients of ringworm infection were 
completely cured in 12–18 days of treatment without any adverse side 
effect. Ointment, when tested for its irritation activity on experimental 
animals, did not show any irritation effect. The same result also 
observed during the patch test method on a human being.
DISCUSSION
During present investigation, E. caryophyllus oil exhibited excellent 
antidermatophytic activity as compared to standard allopathic drugs 
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such as griseofulvin, ketoconazole, and itraconazole. Antifungal and 
antidermatophytic properties of clove were also reported [25,26]. 
Therefore, 1% concentration of oil was used to prepared ointment EC.
A complete treatment time of the different clinical type of tinea 
infection differs from 4 to 10 weeks with different allopathic drugs. 
During treatment, all patients of ringworm infection were completely 
cured in 12–18 days of treatment without any adverse side effects. Out 
of 15 patients of tinea corporis, three cured completely within a week, 
nine after the 2nd week of treatment and the remaining were cured after 
3rd week of treatment. Six patients of tinea capitis and nine of Tinea 
manuum were completely cured in 3rd week of treatment. Likewise, 
all patients of tinea barbae were cured in the 2nd week of treatment. 
Ointment, when tested for its irritation activity on experimental animal, 
did not show any irritation effect. The same result also observed during 
the patch test method on human being.
In our previous work [15], we explored T. ammi essential oil against 
dermatophytes and found excellent results. During the comparative 
analysis of both oils, Eugenia oil exhibited more prominent 
antidermatophytic activity (laboratorically and clinically) as compared 
to T. ammi oil. Shahi et al. [27] also used 1% concentration of Eucalyptus 
citriodora oil against dermatophytic infection of a human being. At 
the end of treatment, 55.5% of patients recovered completely and 
45.5% of them showed significant improvement. Shahi et al. [28] used 
1.0 µl/ml concentration of Eucalyptus pauciflora against selected human 
pathogenic fungi and prepared an ointment (1% v/v) for ringworm 
infections of human beings. At the end, 60% of patients recovered 
completely and 40% showed significant improvement from the disease.
CONCLUSION
The oil of E. caryophyllus due to its strong antifungal activity inhibiting 
heavy doses of inoculum having fungicidal properties and with no 
irritation on human skin can be used successfully in the form of 
broad-spectrum antimycotic drug for the control of superficial fungal 
infection in human beings. E. caryophyllus also exhibited stronger 
antidermatophytic compound as compared to all synthetic antifungal 
drug prescribed by doctors during the course of treatment. These 
have been found to be better and effective substitutes for curing the 
disease without any adverse side effect. They are easy to apply and 
respond much faster than synthetic allopathic preparations. Isolation 
and identification of active principles of E. caryophyllus at different 
temperature interval for antidermatophytic activity are in progress.
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